"pancreatic cancer" trang 6 - tải miễn phí từ tailieunhanh
Malignant extra-adrenal pancreatic paraganglioma: Case report and literature review

Malignant extra-adrenal pancreatic paraganglioma: Case report and literature review
5    60    1
Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head
11    32    1
KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells

KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
29    19    1
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: A meta-analysis of 20 randomized controlled trials

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: A meta-analysis of 20 randomized controlled trials
10    69    0
Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture

Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture
13    90    0
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer
9    77    0
Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer

Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer
8    69    0
MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators

MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators
13    89    0
Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis
11    54    0
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer

Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
10    110    0
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
7    90    0
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
8    77    0
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
6    82    0
Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment
8    73    1
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
10    33    1
Long-term trends in pancreatic cancer mortality in Spain (1952–2012)

Long-term trends in pancreatic cancer mortality in Spain (1952–2012)
10    74    1
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens
9    70    1
Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells

Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells
12    69    1
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
15    38    1
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
13    36    1